Federation des caisses Desjardins du Quebec’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-2,425
Closed -$276 2163
2018
Q4
$276 Hold
2,425
﹤0.01% 2020
2018
Q3
$4.12K Hold
2,425
﹤0.01% 1920
2018
Q2
$4.22K Hold
2,425
﹤0.01% 1927
2018
Q1
$4.44K Sell
2,425
-200
-8% -$422 ﹤0.01% 1891
2017
Q4
$5.85K Sell
2,625
-1,500
-36% -$3.73K ﹤0.01% 1842
2017
Q3
$12K Sell
4,125
-2,200
-35% -$7.5K ﹤0.01% 1626
2017
Q2
$28.1K Hold
6,325
﹤0.01% 1512
2017
Q1
$29.5K Buy
+6,325
New +$36.7K ﹤0.01% 1234

Other funds holding SGYP

Federation des caisses Desjardins du Quebec's SGYP Position: Q1 2019 in Review

Federation des caisses Desjardins du Quebec sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 2,425 shares — an estimated $276 sold.

Federation des caisses Desjardins du Quebec first reported a position in SGYP in Q1 2017 and held it in 8 quarters. The position peaked at $29.5K in Q1 2017. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.

  • Federation des caisses Desjardins du Quebec reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 2,425 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $276.
  • Federation des caisses Desjardins du Quebec first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q1 2017 and held it in 8 quarters.
  • Federation des caisses Desjardins du Quebec's Synergy Pharmaceuticals, Inc Common Stock position peaked at $29.5K in Q1 2017.
  • 12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2019, filed 30 Aug 2024.